Oscar Health, Inc. 2024 Fourth Quarter and Full Year Earnings Conference Call
Oscar Health (NYSE: OSCR) announced it will release its fourth quarter and full year 2024 financial results after market close on Tuesday, February 4, 2025. The healthcare technology company will host a conference call at 5:00 PM ET on the same day to discuss the results. Investors can access the call via phone (1.855.761.5600, Conference ID: 7768132) or webcast. The call recording will be available on Oscar's investor relations website for 90 days following the event.
Oscar Health (NYSE: OSCR) ha annunciato che pubblicherà i suoi risultati finanziari del quarto trimestre e dell'intero anno 2024 dopo la chiusura del mercato martedì 4 febbraio 2025. L'azienda di tecnologia sanitaria ospiterà una conferenza telefonica alle 17:00 ET nello stesso giorno per discutere i risultati. Gli investitori possono accedere alla chiamata telefonicamente (1.855.761.5600, ID Conferenza: 7768132) o tramite webcast. La registrazione della chiamata sarà disponibile sul sito delle relazioni con gli investitori di Oscar per 90 giorni dopo l'evento.
Oscar Health (NYSE: OSCR) anunció que publicará sus resultados financieros del cuarto trimestre y del año completo 2024 después del cierre del mercado el martes 4 de febrero de 2025. La empresa de tecnología de salud llevará a cabo una llamada de conferencia a las 5:00 PM ET el mismo día para discutir los resultados. Los inversores pueden acceder a la llamada por teléfono (1.855.761.5600, ID de Conferencia: 7768132) o a través de webcast. La grabación de la llamada estará disponible en el sitio web de relaciones con inversores de Oscar durante 90 días después del evento.
오스카 헬스 (NYSE: OSCR)는 2025년 2월 4일 화요일 시장 종료 후 2024년 4분기 및 연간 재무 결과를 발표할 것이라고 발표했습니다. 이 헬스케어 기술 회사는 같은 날 오후 5시 ET에 결과를 논의하기 위한 컨퍼런스 콜을 개최할 예정입니다. 투자자는 전화(1.855.761.5600, 회의 ID: 7768132) 또는 웹캐스트를 통해 콜에 접속할 수 있습니다. 콜 녹음은 이벤트 후 90일 동안 오스카의 투자자 관계 웹사이트에서 제공됩니다.
Oscar Health (NYSE: OSCR) a annoncé qu'il publiera ses résultats financiers du quatrième trimestre et de l'année complète 2024 après la clôture du marché le mardi 4 février 2025. La société de technologie de la santé tiendra une conférence téléphonique à 17h00 ET le même jour pour discuter des résultats. Les investisseurs peuvent accéder à l'appel par téléphone (1.855.761.5600, ID de conférence : 7768132) ou par webcast. L'enregistrement de l'appel sera disponible sur le site des relations avec les investisseurs d'Oscar pendant 90 jours suivant l'événement.
Oscar Health (NYSE: OSCR) gab bekannt, dass es seine Finanzergebnisse für das vierte Quartal und das Gesamtjahr 2024 nach Marktschluss am Dienstag, den 4. Februar 2025, veröffentlichen wird. Das Unternehmen für Gesundheitstechnologie wird am gleichen Tag um 17:00 Uhr ET eine Telefonkonferenz abhalten, um die Ergebnisse zu diskutieren. Investoren können die Konferenz über das Telefon (1.855.761.5600, Konferenz-ID: 7768132) oder über einen Webcast erreichen. Die Aufzeichnung der Konferenz wird 90 Tage nach der Veranstaltung auf Oscars Investoren-Website verfügbar sein.
- None.
- None.
Management will review these results in a conference call beginning at 5:00 PM (ET). The call-in number and webcast link are as follows:
Live Call: 1.855.761.5600
Conference ID: 7768132
Webcast
The call will be archived and available on Oscar’s investor relations website (ir.hioscar.com) following February 4, 2025 for a period of 90 days.
About Oscar Health
Oscar Health, Inc. (“Oscar”) is a leading healthcare technology company built around a full stack technology platform and a relentless focus on serving our members. We have been challenging the status quo in the healthcare system since our founding in 2012, and are dedicated to making a healthier life accessible and affordable for all. Oscar offers Individual & Family plans and health technology solutions that power the healthcare industry through +Oscar. Our technology drives superior experiences, deep engagement, and high-value clinical care, earning us the trust of approximately 1.65 million members, as of September 30, 2024.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250109337618/en/
Investor:
Chris Potochar
VP of Investor Relations
ir@hioscar.com
Media:
Kristen Prestano
VP of Communications
press@hioscar.com
Source: Oscar Health, Inc.
FAQ
When will Oscar Health (OSCR) release Q4 and full year 2024 earnings?
How can investors join Oscar Health's Q4 2024 earnings call?
How long will Oscar Health's Q4 2024 earnings call recording be available?
What time is Oscar Health's (OSCR) Q4 2024 earnings conference call?
